Clinical Trials Browser

Phase 2 × Unknown × regramostim × Clear all

NCT02466906 2016-01-20

RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

NCT01806272 2013-03-29

Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis

Phase 2 Unknown

Nasopharyngeal Neoplasms, Stomatitis